000 01813 a2200517 4500
005 20250517051329.0
264 0 _c20160719
008 201607s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.4422
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHo, Chun-Te
245 0 0 _aFolate deficiency-triggered redox pathways confer drug resistance in hepatocellular carcinoma.
_h[electronic resource]
260 _bOncotarget
_cSep 2015
300 _a26104-18 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aBlotting, Western
650 0 4 _aCarcinoma, Hepatocellular
_xgenetics
650 0 4 _aCatechin
_xanalogs & derivatives
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aCulture Media
_xmetabolism
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Resistance, Multiple
_xgenetics
650 0 4 _aDrug Resistance, Neoplasm
_xgenetics
650 0 4 _aEndoplasmic Reticulum Chaperone BiP
650 0 4 _aFolic Acid
_xmetabolism
650 0 4 _aHeat-Shock Proteins
_xgenetics
650 0 4 _aHep G2 Cells
650 0 4 _aHumans
650 0 4 _aInhibitor of Apoptosis Proteins
_xgenetics
650 0 4 _aLiver Neoplasms
_xgenetics
650 0 4 _aOxidation-Reduction
650 0 4 _aRNA Interference
650 0 4 _aReactive Oxygen Species
_xmetabolism
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aSurvivin
700 1 _aShang, Hung-Sheng
700 1 _aChang, Jin-Biou
700 1 _aLiu, Jun-Jen
700 1 _aLiu, Tsan-Zon
773 0 _tOncotarget
_gvol. 6
_gno. 28
_gp. 26104-18
856 4 0 _uhttps://doi.org/10.18632/oncotarget.4422
_zAvailable from publisher's website
999 _c25219785
_d25219785